- Home
- PLX vs NLOP Comparison
PLX vs NLOP Comparison
Compare PLX & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLX | NLOP |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 144.4M |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PLX | NLOP |
|---|---|---|
| Price | $2.55 | $9.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 836.2K | 142.7K |
| Earning Date | 08-12-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.27 | ★ 1.27 |
| Revenue | $52,744,000.00 | ★ $118,915,000.00 |
| Revenue This Year | $55.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.46 | ★ $7.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $9.48 |
| 52 Week High | $3.19 | $30.26 |
Technical Indicators
Market Signals| Indicator | PLX | NLOP |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 35.20 |
| Support Level | $2.21 | $9.50 |
| Resistance Level | $2.75 | $12.19 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 7.41 | 53.66 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.